Find in Library
Search millions of books, articles, and more
Indexed Open Access Databases
Letter to the editor concerning the article ‘Safety of vaccines administration in hereditary fructose intolerance’
oleh: Rebeca Saborido-Fiaño, Nazareth Martinón-Torres, Vanesa Crujeiras-Martinez, Maria Luz Couce, Rosaura Leis
Format: | Article |
---|---|
Diterbitkan: | Taylor & Francis Group 2021-08-01 |
Deskripsi
The most important approach for the management of hereditary fructose intolerance is a strict avoidance of fructose, sucrose and sorbitol from the diet and medications. A safe threshold of 2.4 mg/kg/dose was recently established by the Instituto Superiore di Sanità of Italy for both oral and parenteral routes, thus shouldering a safe administration of a majority of vaccines in these patients. This would not include, Rotarix® pre-established oral suspension and Rotateq® vaccines, which are indeed contraindicated. Moreover, Rotarix® white powder and solvent for oral suspension would only be safely administered at a weight above 9.3 kg. Overall, these recommendations to avoid rotavirus vaccination are difficult to implement because these vaccines are given during exclusive breastfeeding, prior to fructose-containing food introduction.